SCHEMBL18409286

SCHEMBL18409286

CCc1cc(C#N)cc(F)c1Nc1cc2c(ncn2C)c(NC(C)=O)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 4/20 0.47
▸ JAK1 P23458 4/20 0.47
▸ TYK2 P29597 4/20 0.47
▸ JAK3 P52333 4/20 0.47
▸ MAPK8 P45983 2/20 0.34
▸ EGLN2 Q96KS0 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ CTSS P25774 4/20 0.31
▸ CTSK P43235 4/20 0.31
▸ CTSL P07711 2/20 0.31
▸ CTSV O60911 1/20 0.31
▸ CTSB P07858 1/20 0.31
▸ CTSH P09668 1/20 0.31
▸ CASP4 P49662 1/20 0.31
▸ MMP14 P50281 1/20 0.31
▸ CTSC P53634 1/20 0.31
▸ BACE1 P56817 1/20 0.31
▸ ADAM17 P78536 1/20 0.31
▸ CTSZ Q9UBR2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409285 0.89 TYK2 (0.62) JAK2JAK1TYK2JAK3EGLN2
SCHEMBL18398396 0.84 JAK1 (0.44) JAK2JAK1TYK2JAK3MAPK8
SCHEMBL18398397 0.84 JAK2 (0.49) JAK2JAK1TYK2JAK3CTSS
SCHEMBL18409205 0.83 JAK2 (0.40) JAK2JAK1TYK2JAK3MAPK8
SCHEMBL18398361 0.83 JAK2 (0.40) JAK2JAK1TYK2JAK3ALDH1A1
SCHEMBL18398283 0.81 JAK2 (0.63) JAK2JAK1TYK2JAK3EGLN2
SCHEMBL18409117 0.81 TYK2 (0.55) JAK2JAK1TYK2JAK3EGLN2
SCHEMBL18398364 0.78 CYP1A2 (0.41) JAK2JAK1TYK2JAK3ALDH1A1
SCHEMBL18398275 0.78 JAK2 (0.39) JAK2JAK1TYK2JAK3CTSS
SCHEMBL18409322 0.77 TYK2 (0.53) JAK2JAK1TYK2JAK3EGLN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback